Healthcare systems
The economic case for how you deliver care.
We work with hospital groups, regional health authorities, primary care networks, telehealth programs, and health system investors building the economic argument for new models of care.
You are the system making the investment decision.
The question you're answering.
Is this model of care worth the investment, against competing priorities? That's the question we help you answer with the rigour your funders expect.
The scrutiny is real.
Funding committees, Boards, and Ministries of Health ask hard methodological questions. An economic argument that cannot withstand that challenge will not be approved.
We know what funders look for.
We work on both sides of these decisions. We build the economic case for companies seeking adoption by health systems, and we help systems weigh those cases. That cross-perspective is what makes our arguments hold up under board, committee, and ministry-level scrutiny.
Who we work with
Any organisation shaping how care is delivered.
Hospital groups and regional health authorities
Evaluating service redesign, care pathway changes, and investment in new clinical capabilities. Building the economic case for funding bids and Board approval.
Primary care networks
Shifting care out of secondary settings, investing in prevention, or redesigning how chronic disease is managed. Demonstrating value to commissioners and funders.
Telehealth and virtual care programs
Quantifying the economic case for virtual substitution: reduced travel, avoided admissions, earlier intervention. Framed for the funder, not just the clinician.
Point-of-care testing programs
Near-patient diagnostics that change clinical pathways. The economic argument turns on faster decision-making, reduced downstream costs, and patient throughput. We model all three.
Care closer to home initiatives
Shifting secondary and tertiary care into community and home settings. Economic evaluation of the full cost consequence, including what happens when it does not work and patients step back up.
Health system investors and funders
Impact investors, philanthropic funders, and Ministries evaluating portfolio investments in health system change. Independent economic evaluation to support allocation decisions.
What we deliver
Rigorous economic evaluation, built to survive scrutiny.
Every engagement runs on HEX Platform™. That means every parameter has a source, every assumption has a rationale, and every model can be interrogated by your team, not just the economist who built it.
When a funding committee asks a question, the answer is already in the model. When assumptions change mid-process, the model reflects it. That transparency is not just good practice. It is what makes the economic argument defensible.
Cost-effectiveness and cost-consequence analysis
Full economic evaluation of care model changes: costs, outcomes, and the trade-offs between them.
Budget impact and commissioning analysis
What does adoption cost the system, over what timeframe, and against what baseline? Modelled for the decision-maker, not the service provider.
Pathway throughput and capacity modelling
How care pathway changes affect patient flow, wait times, and system capacity. Quantified in economic terms for planning and funding purposes.
Funding bid and Ministry submission support
Economic narrative and supporting analysis for funding applications to Ministries of Health, regional health authorities, or philanthropic bodies.
If you need to make an economic argument for a change in how care is delivered, let's talk.
A short call to understand the decision you're trying to support and where an economic case can carry the most weight.